Baker Ellis Asset Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.26M Buy
3,545
+9
+0.3% +$9.12K 0.39% 67
2025
Q4
$3.8M Buy
3,536
+75
+2% +$71.7K 0.46% 55
2025
Q3
$2.64M Buy
3,461
+3,061
+765% +$2.28M 0.33% 72
2025
Q2
$312K Hold
400
0.04% 182
2025
Q1
$330K Sell
400
-30
-7% -$25K 0.05% 178
2024
Q4
$332K Buy
430
+30
+8% +$24.8K 0.05% 170
2024
Q3
$354K Hold
400
0.05% 172
2024
Q2
$362K Sell
400
-35
-8% -$28K 0.05% 161
2024
Q1
$338K Buy
435
+35
+9% +$24.9K 0.05% 167
2023
Q4
$233K Hold
400
0.04% 191
2023
Q3
$215K Buy
+400
New +$206K 0.04% 192
2017
Q2
Sell
-1,700
Closed -$143K 243
2017
Q1
$143K Hold
1,700
0.04% 214
2016
Q4
$125K Buy
+1,700
New +$127K 0.04% 221

Other funds holding LLY

Baker Ellis Asset Management's LLY Position: Q1 2026 in Review

Baker Ellis Asset Management increased its Eli Lilly (LLY) stake by 0.25% in Q1 2026, buying an estimated $9.12K and bringing the position to 3,545 shares worth $3.26M. The position accounts for 0.39% of the portfolio, ranked #67.

Baker Ellis Asset Management first reported a position in LLY in Q4 2016 and has held it in 13 quarters since. The position peaked at $3.8M in Q4 2025. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Baker Ellis Asset Management held 3,545 shares of Eli Lilly worth $3.26M as of Q1 2026.
  • Baker Ellis Asset Management bought 9 Eli Lilly shares in Q1 2026, an estimated $9.12K.
  • Eli Lilly made up 0.39% of Baker Ellis Asset Management's portfolio in Q1 2026, its #67 holding.
  • Baker Ellis Asset Management first reported a position in Eli Lilly in Q4 2016 and has held it in 13 quarters since.
  • Baker Ellis Asset Management's Eli Lilly position peaked at $3.8M in Q4 2025.
  • 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Baker Ellis Asset Management's 13F filing for Q1 2026, filed 17 Apr 2026.